EMPE
Desconocido
mfloDx: An Adaptable Multiflow Diagnostic Platform to Genetically Identify Drug Resistant Infection
EMPE DIAGNOSTICS AB
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
Tuberculosis (TB) kills more people than any other pathogen-borne illness; yearly, 10M people fall ill and 1.6M die. TB also contributes to...
2021-05-18 - 2024-02-29 | Financiado
2021-05-18 - 2024-02-29 | Financiado
mfloDx: Adaptable Multiflow Diagnostic Platform to Genetically Identify Drug Resistant Infection
EMPE DIAGNOSTICS AB
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
Tuberculosis (TB) killed 33 million people worldwide in 2000-2015 and infects an estimated ¼ of the world population. Drug-resistant forms o...
2019-11-04 - 2020-03-31 | Financiado
2019-11-04 - 2020-03-31 | Financiado
INNOVA4TB: Innovation in Tuberculosis
EMPE DIAGNOSTICS AB
participó en un
H2020:
H2020-MSCA-RISE-2018
The objective of INNOVA4TB is to enhance and strengthen the collaborative research among sectors and to form a network aimed to perform high...
2018-10-04 - 2024-06-30 | Financiado
2018-10-04 - 2024-06-30 | Financiado
* No se disponen de datos de la empresa actual.